179 related articles for article (PubMed ID: 26827394)
1. The Right to Try: An Overview of Efforts to Obtain Expedited Access to Unapproved Treatment for the Terminally Ill.
Tsakopoulos A; Han J; Nodler H; Russo V
Food Drug Law J; 2015; 70(4):617-41. PubMed ID: 26827394
[No Abstract] [Full Text] [Related]
2. "Right-to-Try" Legislation: Progress or Peril?
Yang YT; Chen B; Bennett C
J Clin Oncol; 2015 Aug; 33(24):2597-9. PubMed ID: 26195722
[No Abstract] [Full Text] [Related]
3. "Right to Try" laws.
Begg CB; Kim K; Neaton JD
Clin Trials; 2014 Oct; 11(5):519-20. PubMed ID: 25190026
[No Abstract] [Full Text] [Related]
4. Access before approval--a right to take experimental drugs?
Okie S
N Engl J Med; 2006 Aug; 355(5):437-40. PubMed ID: 16885545
[No Abstract] [Full Text] [Related]
5. The strange allure of state "right-to-try" laws.
Zettler PJ; Greely HT
JAMA Intern Med; 2014 Dec; 174(12):1885-6. PubMed ID: 25264589
[No Abstract] [Full Text] [Related]
6. Right to try?
Lieu CH; Sorkin A; Messersmith WA
J Clin Oncol; 2015 May; 33(13):1518. PubMed ID: 25779561
[No Abstract] [Full Text] [Related]
7. Questions of Safety and Fairness Raised as Right-to-Try Movement Gains Steam.
Jacob JA
JAMA; 2015 Aug; 314(8):758-60. PubMed ID: 26244653
[No Abstract] [Full Text] [Related]
8. Minnesota's Right to Try law.
Hermer LD
Minn Med; 2016; 99(1):30-2. PubMed ID: 26897894
[No Abstract] [Full Text] [Related]
9. Right-to-try laws: hope, hype, and unintended consequences.
Bateman-House A; Kimberly L; Redman B; Dubler N; Caplan A
Ann Intern Med; 2015 Nov; 163(10):796-7. PubMed ID: 26413841
[No Abstract] [Full Text] [Related]
10. Right to experimental treatment: FDA new drug approval, constitutional rights, and the public's health.
Leonard EW
J Law Med Ethics; 2009; 37(2):269-79. PubMed ID: 19493072
[TBL] [Abstract][Full Text] [Related]
11. Health roundup.
Kennedy D
Science; 2006 May; 312(5777):1105. PubMed ID: 16728598
[No Abstract] [Full Text] [Related]
12. Patient advocacy. 'Right to Try' laws bypass FDA for last-ditch treatments.
Servick K
Science; 2014 Jun; 344(6190):1329. PubMed ID: 24948714
[No Abstract] [Full Text] [Related]
13. The terminally ill, access to investigational drugs, and FDA rules.
Blake V
Virtual Mentor; 2013 Aug; 15(8):687-91. PubMed ID: 23937785
[No Abstract] [Full Text] [Related]
14. The Federal Right to Try Act of 2017-A Wrong Turn for Access to Investigational Drugs and the Path Forward.
Bateman-House A; Robertson CT
JAMA Intern Med; 2018 Mar; 178(3):321-322. PubMed ID: 29356821
[No Abstract] [Full Text] [Related]
15. Should terminally ill patients have access to phase I drugs?
Bristol N
Lancet; 2007 Mar; 369(9564):815-6. PubMed ID: 17366691
[No Abstract] [Full Text] [Related]
16. The proper focus for FDA regulations: why the fundamental right to self-preservation should allow terminally ill patients with no treatment options to attempt to save their lives.
Puckett A
SMU Law Rev; 2007; 60(2):635-65. PubMed ID: 17849632
[No Abstract] [Full Text] [Related]
17. Experts critical of America's right-to-try drug laws.
Rubin R
Lancet; 2015 Oct; 386(10001):1325-6. PubMed ID: 26460764
[No Abstract] [Full Text] [Related]
18. On Patient Safety: A Right to Try, Not Exploit.
Rickert J
Clin Orthop Relat Res; 2021 Jul; 479(7):1435-1437. PubMed ID: 34086009
[No Abstract] [Full Text] [Related]
19. Individual patient treatment use of unapproved drugs: a new option for the seriously ill.
Simon LS; Green A
J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):19-22. PubMed ID: 20345195
[TBL] [Abstract][Full Text] [Related]
20. No way to save a life: allowing terminally ill patients access to drugs that have not completed clinical trials is a dangerous move.
Moss RW
New Sci; 2006 Jun 3-9; 190(2554):21. PubMed ID: 16832956
[No Abstract] [Full Text] [Related]
[Next] [New Search]
